泓博医药
(301230)
| 流通市值：62.63亿 | | | 总市值：69.63亿 |
| 流通股本：1.63亿 | | | 总股本：1.81亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 364,406,306.14 | 172,285,876.53 | 688,350,863.65 | 514,401,151.54 |
| 营业总成本 | 348,643,419.8 | 159,696,084.51 | 655,923,295.42 | 484,120,946.96 |
| 其他经营收益 | | | | |
| 营业利润 | 31,471,609.65 | 26,398,618.34 | 28,621,094.95 | 32,017,358.51 |
| 利润总额 | 30,134,483.58 | 25,984,761.82 | 28,316,885.7 | 31,825,220.45 |
| 净利润 | 28,729,363.74 | 23,779,249.5 | 34,294,767.32 | 34,749,579.26 |
| 每股收益 | | | | |
| 其他综合收益 | -3,995.55 | -114,466.4 | -17,625.94 | -79,436.07 |
| 综合收益总额 | 28,725,368.19 | 23,664,783.1 | 34,277,141.38 | 34,670,143.19 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 565,319,888.89 | 578,133,505.52 | 582,095,905.67 | 562,877,685.5 |
| 非流动资产: | | | | |
| 非流动资产合计 | 737,109,783.65 | 737,709,880.14 | 732,003,270.12 | 742,666,439.86 |
| 资产总计 | 1,302,429,672.54 | 1,315,843,385.66 | 1,314,099,175.79 | 1,305,544,125.36 |
| 流动负债: | | | | |
| 流动负债合计 | 167,799,625.09 | 153,754,515.99 | 172,212,045.67 | 138,007,757.07 |
| 非流动负债: | | | | |
| 非流动负债合计 | 122,164,168.4 | 132,137,306.02 | 137,657,022.3 | 141,353,423.12 |
| 负债合计 | 289,963,793.49 | 285,891,822.01 | 309,869,067.97 | 279,361,180.19 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,012,465,879.05 | 1,029,951,563.65 | 1,004,230,107.82 | 1,026,182,945.17 |
| 股东权益合计 | 1,012,465,879.05 | 1,029,951,563.65 | 1,004,230,107.82 | 1,026,182,945.17 |
| 负债和股东权益合计 | 1,302,429,672.54 | 1,315,843,385.66 | 1,314,099,175.79 | 1,305,544,125.36 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 346,125,903.8 | 176,532,345.46 | 604,871,381.42 | 451,715,185.39 |
| 经营活动现金流出小计 | 274,111,094.43 | 146,784,870.1 | 469,359,439.29 | 369,200,872.98 |
| 经营活动产生的现金流量净额 | 72,014,809.37 | 29,747,475.36 | 135,511,942.13 | 82,514,312.41 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 257,573,696.95 | 167,625,628.12 | 23,226,822.53 | 20,105,380.53 |
| 投资活动现金流出小计 | 262,425,629.61 | 172,118,035.78 | 66,616,262.01 | 53,694,584.71 |
| 投资活动产生的现金流量净额 | -4,851,932.66 | -4,492,407.66 | -43,389,439.48 | -33,589,204.18 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 9,399,800 | - | 25,664,755.58 | 25,664,755.58 |
| 筹资活动现金流出小计 | 39,928,726.76 | 19,808,244.53 | 105,533,456.16 | 81,683,294.51 |
| 筹资活动产生的现金流量净额 | -30,528,926.76 | -19,808,244.53 | -79,868,700.58 | -56,018,538.93 |
| 汇率变动对现金及现金等价物的影响 | -2,973,470.67 | -1,553,587.61 | 1,815,915.65 | 2,251,028.46 |
| 现金及现金等价物净增加额 | 33,660,479.28 | 3,893,235.56 | 14,069,717.72 | -4,842,402.24 |
| 期末现金及现金等价物余额 | 86,479,144.17 | 56,711,900.45 | 52,818,664.89 | 33,906,544.93 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 33,660,479.28 | - | 14,069,717.72 | - |